These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25367314)

  • 61. Cost-effectiveness of treating resistant hypertension with an implantable carotid body stimulator.
    Young KC; Teeters JC; Benesch CG; Bisognano JD; Illig KA
    J Clin Hypertens (Greenwich); 2009 Oct; 11(10):555-63. PubMed ID: 19817936
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation.
    Mahfoud F; Tunev S; Ewen S; Cremers B; Ruwart J; Schulz-Jander D; Linz D; Davies J; Kandzari DE; Whitbourn R; Böhm M; Melder RJ
    J Am Coll Cardiol; 2015 Oct; 66(16):1766-1775. PubMed ID: 26483099
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Potential cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension.
    Chung O; Vongpatanasin W; Bonaventura K; Lotan Y; Sohns C; Haverkamp W; Dorenkamp M
    J Hypertens; 2014 Dec; 32(12):2411-21; discussion 2421. PubMed ID: 25255395
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Potential health impact and cost-effectiveness of drug therapy for prehypertension.
    Chen T; Yu D; Cornelius V; Qin R; Cai Y; Jiang Z; Zhao Z
    Int J Cardiol; 2017 Aug; 240():403-408. PubMed ID: 28501349
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-term quality of life and clinical outcomes in patients with resistant hypertension treated with renal denervation.
    Krawczyk-Ożóg A; Tokarek T; Moczała K; Siudak Z; Dziewierz A; Mielecki W; Górecki T; Gerba K; Dudek D
    Postepy Kardiol Interwencyjnej; 2016; 12(4):329-333. PubMed ID: 27980546
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Modelling the Cost-Effectiveness of Implementing a Dietary Intervention in Renal Transplant Recipients.
    Coerts FB; Gout-Zwart JJ; Gruppen EG; van der Veen Y; Postma MJ; Bakker SJL
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33918259
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Renal denervation for refractory hypertension - technical aspects, complications and radiation exposure.
    Scheurig-Muenkler C; Weiss W; Foert E; Toelle M; van der Giet M; Kröncke TJ; Zidek W; Powerski MJ
    Rofo; 2013 Jun; 185(6):550-7. PubMed ID: 23471681
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Renal denervation in resistant hypertension: proposal for a common multidisciplinary attitude].
    Muller O; Qanadli SD; Waeber B; Wuerzner G
    Rev Med Suisse; 2012 May; 8(343):1159-60, 1162-3. PubMed ID: 22741177
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Non-invasive Renal Denervation: Update on External Ultrasound Approaches.
    Schmieder RE; Ott C; Bramlage P
    Curr Hypertens Rep; 2016 Jun; 18(6):48. PubMed ID: 27137523
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertension.
    Tzafriri AR; Keating JH; Markham PM; Spognardi AM; Stanley JR; Wong G; Zani BG; Highsmith D; O'Fallon P; Fuimaono K; Mahfoud F; Edelman ER
    Sci Transl Med; 2015 Apr; 7(285):285ra65. PubMed ID: 25925684
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Executive summary of the joint position paper on renal denervation of the Cardiovascular and Interventional Radiological Society of Europe and the European Society of Hypertension.
    Moss JG; Belli AM; Coca A; Lee M; Mancia G; Peregrin JH; Redon J; Reekers JA; Tsioufis C; Vorwerk D; Schmieder RE
    J Hypertens; 2016 Dec; 34(12):2303-2304. PubMed ID: 27755387
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The position of renal denervation in treatment of hypertension: an expert consensus statement.
    Zeijen VJM; Kroon AA; van den Born BH; Blankestijn PJ; Meijvis SCA; Nap A; Lipsic E; Elvan A; Versmissen J; van Geuns RJ; Voskuil M; Tonino PAL; Spiering W; Deinum J; Daemen J
    Neth Heart J; 2023 Jan; 31(1):3-11. PubMed ID: 36001280
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A dynamic Markov model to assess the cost-effectiveness of the Kidney Team at Home intervention in The Netherlands.
    Redeker S; Ismail S; Eeren HV; Massey EK; Weimar W; Oppe M; Busschbach J;
    Eur J Health Econ; 2022 Jun; 23(4):597-606. PubMed ID: 34647158
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cost-effectiveness of a peer and practice staff support intervention.
    Hollenbeak CS; Weiner MG; Turner BJ
    Am J Manag Care; 2014 Mar; 20(3):253-60. PubMed ID: 24884753
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Three-dimensional guided renal denervation to treat drug-resistant arterial hypertension in a patient with renal insufficiency.
    Lewalter T; Brodherr T
    Hypertension; 2012 Oct; 60(4):e33. PubMed ID: 22914794
    [No Abstract]   [Full Text] [Related]  

  • 76. Renal denervation therapy for hypertension: pathways for moving development forward.
    White WB; Galis ZS; Henegar J; Kandzari DE; Victor R; Sica D; Townsend RR; Turner JR; Virmani R; Mauri L
    J Am Soc Hypertens; 2015 May; 9(5):341-50. PubMed ID: 25979410
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands.
    Lenoir-Wijnkoop I; van Aalderen WM; Boehm G; Klaassen D; Sprikkelman AB; Nuijten MJ
    Eur J Health Econ; 2012 Feb; 13(1):101-10. PubMed ID: 21165666
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of value-of-information analysis in a health care research priority setting: a theoretical case study.
    Corro Ramos I; Rutten-van Mölken MP; Al MJ
    Med Decis Making; 2013 May; 33(4):472-89. PubMed ID: 23275451
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ablation points of renal sympathetic denervation: the more, the better?
    Xiao Y; Zhou S; Liu Q
    Hypertension; 2012 Dec; 60(6):e47. PubMed ID: 23108650
    [No Abstract]   [Full Text] [Related]  

  • 80. Design of renal denervation studies not confounded by antihypertensive drugs.
    Kjeldsen SE; Persu A; Azizi M
    J Am Soc Hypertens; 2015 May; 9(5):337-40. PubMed ID: 25863572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.